Netherlands· NL-30d7c101d6ae
Fenobarbital Teva 50 mg, tabletten
A phenobarbital product containing fenobarbital, registered in Netherlands by Teva Nederland B.V.. The same ATC class is registered in 15 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Phenobarbital is registered in 15 of 19 countries.
Countries holding a registration under ATC N03AA02 (phenobarbital), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 8 of them publish a price we can compare per daily dose
Phenobarbital · ATC N03AA02
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of phenobarbital costs, country by country.
Normalised to the WHO defined daily dose (0.1 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Phenobarbital · price per daily dose (0.1 g)
USD · FX 28 Sept 2026
- IT Italy$0.10
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- FENOBARBITAL
- Manufacturer
- Teva Nederland B.V.
- Country
- Netherlands (NL)
- ATC code
- N03AA02
- ATC class
- Phenobarbital
- Defined daily dose
- 0.1 g, O
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id52101
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
433 interactions on record for phenobarbital.
Graded by severity as the source publishes them — 133 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Phenobarbital · interactions on record
433 records
- 133 severe
- 236 moderate
- 19 minor
Most severe, free to view
- RolapitantA04AD14severe
- NaloxegolA06AH03severe
- NaldemedineA06AH05severe
- EliglustatA16AX10severe
45 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Phenobarbital in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwitzerlandAphenylbarbit 50 mg, TablettenStreuli Pharma AG
- SpainGARDENAL 50 mg COMPRIMIDOSSanofi Aventis S.A.
- FinlandPhenoleptil vetDechra Regulatory B.V.
- FranceGARDENAL 50 mg, compriméATNAHS PHARMA FRANCE
- NorwayFenemalOrifarm Healthcare A/S
- United StatesPhenobarbitalREMEDYREPACK INC.
- United KingdomGardenal Sodium 200mg/1ml solution for injection ampoulesConcord Pharmaceuticals Ltd
- CanadaEPIPHEN 30MGVETOQUINOL N A INC
Authorised across Europe · EMA
The same active substance is authorised in 20 EEA countries. Names it is sold under:
- Belgium · Gardenal, Phenobarbital Sodium Sterop
- Bulgaria · Фенобарбитал Софарма
- Czechia · Luminal, Phenaemal
- Germany · Luminal, Luminaletten
- Denmark · Fenemal
- Estonia · Phenaemal
- Spain · Luminal, Luminaletas
- France · Gardenal
- United Kingdom (Northern Ireland) · Phenobarbital Accord, Phenobarbital Activase
- Greece · Gardenal
- Croatia · Phenobarbiton
- Hungary · Sevenal, Sevenaletta
- Ireland · Phenobarbital Clonmel Healthcare
- Italy · Fenobarbitale Sodico S.A.L.F, Gardenale
- Luxembourg · Gardenal
- Norway · Fenemal
- Poland · Luminalum, Luminalum Unia
- Portugal · Bialminal, Fenobarbital Labesfal
- Romania · Fenobarbital Arena, Fenobarbital Zentiva
- Slovakia · Luminal, Phenaemal 0,1
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/bc97c51e-e4c7-46cf-8edf-e84453426d71 GET /v1/drugs/bc97c51e-e4c7-46cf-8edf-e84453426d71?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tablet",
"route": "Oraal gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h52101_smpc.pdf",
"strength": null,
"atc_label": "Phenobarbital",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg52101",
"excipients": [
"LACTOSE 1-WATER",
"MAGNESIUMSTEARAAT (E 470b)",
"NATRIUMZETMEELGLYCOLAAT",
"SILICIUMDIOXIDE (E 551)",
"TARWEZETMEEL",
"ZETMEEL, GEPREGELATINEERD"
],
"substances": [
"FENOBARBITAL"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h52101.pdf",
"authorised_at": "1992/12/14",
"procedure_number": null,
"dispensing_status": "Uitsluitend recept",
"registration_number": "52101",
"additional_monitoring": "N"
}See everything about phenobarbital.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.